[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound

Focused ultrasound in combination with microbubbles (FUS) provides an effective means to locally enhance the delivery of therapeutics to the brain. Translational and quantitative imaging techniques are needed to noninvasively monitor and optimize the impact of FUS on blood-brain barrier (BBB) permea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gaëlle Hugon, Sébastien Goutal, Ambre Dauba, Louise Breuil, Benoit Larrat, Alexandra Winkeler, Anthony Novell, Nicolas Tournier
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8725d3f997024c7cada22894fcce8252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8725d3f997024c7cada22894fcce8252
record_format dspace
spelling oai:doaj.org-article:8725d3f997024c7cada22894fcce82522021-11-25T18:40:22Z[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound10.3390/pharmaceutics131117521999-4923https://doaj.org/article/8725d3f997024c7cada22894fcce82522021-10-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1752https://doaj.org/toc/1999-4923Focused ultrasound in combination with microbubbles (FUS) provides an effective means to locally enhance the delivery of therapeutics to the brain. Translational and quantitative imaging techniques are needed to noninvasively monitor and optimize the impact of FUS on blood-brain barrier (BBB) permeability in vivo. Positron-emission tomography (PET) imaging using [<sup>18</sup>F]2-fluoro-2-deoxy-sorbitol ([<sup>18</sup>F]FDS) was evaluated as a small-molecule (paracellular) marker of blood-brain barrier (BBB) integrity. [<sup>18</sup>F]FDS was straightforwardly produced from chemical reduction of commercial [<sup>18</sup>F]2-deoxy-2-fluoro-D-glucose. [<sup>18</sup>F]FDS and the invasive BBB integrity marker Evan’s blue (EB) were i.v. injected in mice after an optimized FUS protocol designed to generate controlled hemispheric BBB disruption. Quantitative determination of the impact of FUS on the BBB permeability was determined using kinetic modeling. A 2.2 ± 0.5-fold higher PET signal (<i>n</i> = 5; <i>p</i> < 0.01) was obtained in the sonicated hemisphere and colocalized with EB staining observed post mortem. FUS significantly increased the blood-to-brain distribution of [<sup>18</sup>F]FDS by 2.4 ± 0.8-fold (<i>V</i><sub>T</sub>; <i>p</i> < 0.01). Low variability (=10.1%) of <i>V</i><sub>T</sub> values in the sonicated hemisphere suggests reproducibility of the estimation of BBB permeability and FUS method. [<sup>18</sup>F]FDS PET provides a readily available, sensitive and reproducible marker of BBB permeability to noninvasively monitor the extent of BBB disruption induced by FUS in vivo.Gaëlle HugonSébastien GoutalAmbre DaubaLouise BreuilBenoit LarratAlexandra WinkelerAnthony NovellNicolas TournierMDPI AGarticleblood-brain barrierintegrity markersorbitolpositron emission tomographyfocused ultrasoundPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1752, p 1752 (2021)
institution DOAJ
collection DOAJ
language EN
topic blood-brain barrier
integrity marker
sorbitol
positron emission tomography
focused ultrasound
Pharmacy and materia medica
RS1-441
spellingShingle blood-brain barrier
integrity marker
sorbitol
positron emission tomography
focused ultrasound
Pharmacy and materia medica
RS1-441
Gaëlle Hugon
Sébastien Goutal
Ambre Dauba
Louise Breuil
Benoit Larrat
Alexandra Winkeler
Anthony Novell
Nicolas Tournier
[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
description Focused ultrasound in combination with microbubbles (FUS) provides an effective means to locally enhance the delivery of therapeutics to the brain. Translational and quantitative imaging techniques are needed to noninvasively monitor and optimize the impact of FUS on blood-brain barrier (BBB) permeability in vivo. Positron-emission tomography (PET) imaging using [<sup>18</sup>F]2-fluoro-2-deoxy-sorbitol ([<sup>18</sup>F]FDS) was evaluated as a small-molecule (paracellular) marker of blood-brain barrier (BBB) integrity. [<sup>18</sup>F]FDS was straightforwardly produced from chemical reduction of commercial [<sup>18</sup>F]2-deoxy-2-fluoro-D-glucose. [<sup>18</sup>F]FDS and the invasive BBB integrity marker Evan’s blue (EB) were i.v. injected in mice after an optimized FUS protocol designed to generate controlled hemispheric BBB disruption. Quantitative determination of the impact of FUS on the BBB permeability was determined using kinetic modeling. A 2.2 ± 0.5-fold higher PET signal (<i>n</i> = 5; <i>p</i> < 0.01) was obtained in the sonicated hemisphere and colocalized with EB staining observed post mortem. FUS significantly increased the blood-to-brain distribution of [<sup>18</sup>F]FDS by 2.4 ± 0.8-fold (<i>V</i><sub>T</sub>; <i>p</i> < 0.01). Low variability (=10.1%) of <i>V</i><sub>T</sub> values in the sonicated hemisphere suggests reproducibility of the estimation of BBB permeability and FUS method. [<sup>18</sup>F]FDS PET provides a readily available, sensitive and reproducible marker of BBB permeability to noninvasively monitor the extent of BBB disruption induced by FUS in vivo.
format article
author Gaëlle Hugon
Sébastien Goutal
Ambre Dauba
Louise Breuil
Benoit Larrat
Alexandra Winkeler
Anthony Novell
Nicolas Tournier
author_facet Gaëlle Hugon
Sébastien Goutal
Ambre Dauba
Louise Breuil
Benoit Larrat
Alexandra Winkeler
Anthony Novell
Nicolas Tournier
author_sort Gaëlle Hugon
title [<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
title_short [<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
title_full [<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
title_fullStr [<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
title_full_unstemmed [<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
title_sort [<sup>18</sup>f]2-fluoro-2-deoxy-sorbitol pet imaging for quantitative monitoring of enhanced blood-brain barrier permeability induced by focused ultrasound
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/8725d3f997024c7cada22894fcce8252
work_keys_str_mv AT gaellehugon sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT sebastiengoutal sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT ambredauba sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT louisebreuil sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT benoitlarrat sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT alexandrawinkeler sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT anthonynovell sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
AT nicolastournier sup18supf2fluoro2deoxysorbitolpetimagingforquantitativemonitoringofenhancedbloodbrainbarrierpermeabilityinducedbyfocusedultrasound
_version_ 1718410846485348352